BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6293259)

  • 1. Carcinoma of the ovary in stage III. Effects of postoperative chemotherapy, radiation therapy and repeat laparotomy.
    Sigurdsson K; Johnsson JE; Tropé C
    Acta Radiol Oncol; 1982; 21(3):181-9. PubMed ID: 6293259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced stage III ovarian carcinoma. Prospective randomized trials comparing radiotherapy and chemotherapy.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1986; 65(1):69-74. PubMed ID: 3521187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for common epithelial tumors of the ovary.
    Wharton JT; Herson J
    Cancer; 1981 Jul; 48(2 Suppl):582-9. PubMed ID: 7023667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma.
    Fuller DB; Sause WT; Plenk HP; Menlove RL
    J Clin Oncol; 1987 Jun; 5(6):897-905. PubMed ID: 3585445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
    Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative irradiation in stage III carcinoma of the ovary.
    Kjørstad KE; Welander C; Kolstad P
    Acta Obstet Gynecol Scand; 1977; 56(4):449-52. PubMed ID: 414511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy.
    Kapp KS; Kapp DS; Poschauko J; Stücklschweiger GF; Hackl A; Pickel H; Petru E; Winter R
    Gynecol Oncol; 1999 Sep; 74(3):400-7. PubMed ID: 10479500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postoperative radiotherapy of epithelial ovarian cancers].
    Kucera H; Sevelda P; Genger H; Weghaupt K
    Geburtshilfe Frauenheilkd; 1985 Dec; 45(12):848-52. PubMed ID: 4085759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfractionation of whole-abdomen radiation therapy: salvage treatment of persistent ovarian carcinoma following chemotherapy.
    Morgan L; Chafe W; Mendenhall W; Marcus R
    Gynecol Oncol; 1988 Sep; 31(1):122-36. PubMed ID: 3410343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of epithelial cancer of the ovary. In favor of primary radical and regional surgery before chemotherapy and radiotherapy].
    Joyeux H; Saint-Aubert B; Gouttebel MC; Zhang GH; Domergue J; Dubois JB; Cupissol D
    Presse Med; 1987 Jul 11-18; 16(27):1325-8. PubMed ID: 2956592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of the ovary, stages I and II. A prospective randomized study of the effects of postoperative chemotherapy and radiotherapy.
    Sigurdsson K; Johnsson JE; Tropé C
    Ann Chir Gynaecol; 1982; 71(6):321-9. PubMed ID: 6297368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative irradiation and chemotherapy in patients with advanced ovarian cancer.
    Welander C; Kjørstad KE; Kolstad P
    Acta Obstet Gynecol Scand; 1978; 57(2):161-4. PubMed ID: 416647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaparotomy in advanced ovarian carcinoma.
    Frick G; Johnsson JE; Landberg T; Snorradottir M
    Acta Obstet Gynecol Scand; 1978; 57(2):165-8. PubMed ID: 636857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinoma.
    Hoskins WJ; Lichter AS; Whittington R; Artman LE; Bibro MC; Park RC
    Gynecol Oncol; 1985 Mar; 20(3):271-80. PubMed ID: 3972290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR).
    Weiser EB; Burke TW; Heller PB; Woodward J; Hoskins WJ; Park RC
    Gynecol Oncol; 1988 Jun; 30(2):201-8. PubMed ID: 3371745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian epithelial tumors of low malignant potential.
    Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
    Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
    Varia MA; Stehman FB; Bundy BN; Benda JA; Clarke-Pearson DL; Alvarez RD; Long HJ;
    J Clin Oncol; 2003 Aug; 21(15):2849-55. PubMed ID: 12885800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of high dose abdominopelvic radiotherapy following surgery and chemotherapy for stage III epithelial carcinoma of the ovary.
    Coltart RS; Nethersell AB; Brown CH
    Gynecol Oncol; 1986 Jan; 23(1):105-10. PubMed ID: 3510945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.